Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
208.49
+0.86 (+0.41%)
Streaming Delayed Price
Updated: 2:34 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,125,431
Open
208.00
Bid (Size)
208.47 (100)
Ask (Size)
208.50 (100)
Prev. Close
207.63
Today's Range
207.90 - 209.47
52wk Range
140.68 - 215.19
Shares Outstanding
2,628,679,824
Dividend Yield
2.49%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031?
↗
Today 11:43 EST
All three are buys, but for different reasons.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Intellectual Property
The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
Today 10:37 EST
As the final trading days of 2025 unfold, the festive exuberance that propelled Wall Street to the brink of historic milestones is beginning to cool. After a blistering mid-December surge that saw the...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Performance
YTD
+44.8%
+44.8%
1 Month
+0.8%
+0.8%
3 Month
+14.8%
+14.8%
6 Month
+36.5%
+36.5%
1 Year
+45.4%
+45.4%
More News
Read More
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
Today 10:28 EST
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Earnings
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
Today 8:00 EST
From
Johnson & Johnson
Via
Business Wire
Blue-Chip Bull Run: Dow Jones Eyes 50,000 Milestone Amidst 2026 Technical Pivot
December 26, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
December 26, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit
↗
December 26, 2025
Via
Stocktwits
Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss
↗
December 26, 2025
Via
Benzinga
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
December 26, 2025
Via
PredictStreet
Topics
Economy
Emissions
Product Recall
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
This Dividend ETF Could Quietly Make You a Multimillionaire Over Time
↗
December 24, 2025
Via
The Motley Fool
Topics
ETFs
Top 5 US Healthcare Stocks By Market Value
↗
December 24, 2025
Via
Stocktwits
Legal Seismic Shift: Johnson & Johnson Faces Record $1.5 Billion Talc Verdict as Bankruptcy Strategy Collapses
December 23, 2025
Via
MarketMinute
Topics
Bankruptcy
Bonds
Lawsuit
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
December 23, 2025
Via
MarketMinute
Topics
Economy
The Dividend King Buy-and-Hold Strategy That Can Surge 100% in 10 Years
↗
December 23, 2025
Via
The Motley Fool
Johnson & Johnson Hit With Record $1.5 Billion US Verdict Over Talc Cancer Claim
↗
December 23, 2025
Via
Benzinga
The Great Consolidation: Why 2026 is Set to Become the 'Year of the Mega-Deal'
December 22, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
What to Expect From Johnson & Johnson’s Next Quarterly Earnings Report
December 22, 2025
Via
Barchart.com
Topics
ETFs
Why a Minnesota Jury Ordered Johnson & Johnson To Pay $65.5 Million in Damages
↗
December 20, 2025
Via
Benzinga
The 10% Shadow: Analyzing the Growing Risk of a 30% Market Correction in 2026
December 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen.
↗
December 18, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
FDA Approves J&J's New 5-Minute Injection For Lung Cancer
↗
December 18, 2025
Via
Benzinga
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 208.49
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 12/29/25 02:34 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 548.05B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 548B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.